110
Participants
Start Date
May 23, 2024
Primary Completion Date
July 1, 2025
Study Completion Date
December 31, 2025
Evaluation of transcriptomic and cardio-metabolic profiles
The parameters and variables collected in 2006-2007 (T0) will be re-evaluated at the follow-up visit (T1), including demographic, anthropometric, lifestyle data (smoking habit, physical activity, sleep quality) blood pressure, standard biochemical analysis and inflammatory profile. To assess the evolution of glucose tolerance and vascular damage, metabolic (OGTT) and cardiovascular (carotid ecodoppler) profile analyses will be repeated. For gene expression analyses, in addition to messenger RNA from PBMCs (as at T0), RNA from PBMC-derived monocytes will also be extracted and sequenced at T1.
University of Parma, Department of Medicine and Surgery, Parma
University of Parma
OTHER
Azienda Ospedaliero-Universitaria di Parma
OTHER